Cover Image for H7 Life Science VC Showcase 2025 Online
Cover Image for H7 Life Science VC Showcase 2025 Online

H7 Life Science VC Showcase 2025 Online

Hosted by H7 BioCapital & Marketing H7
Virtual
Registration
Welcome! To join the event, please register below.
About Event

We are thrilled to announce the H7 Life Science VC Showcase 2025 — a premier virtual event spotlighting the most promising early-stage startups in Life Sciences. Hosted by H7 BioCapital, this showcase features two focused pitch tracks in Therapeutics and Medtech, where standout founders will present to leading healthcare VCs.

In addition to high-impact startup pitches, the event includes timely panel discussions with top investors, legal experts, and operators on scaling biotech companies and navigating today’s venture landscape. Whether you're an investor, founder, or healthcare innovator, this is your front-row seat to the next wave of breakthroughs.

Startups interested in pitching can apply here. If you have any questions, please don't hesitate to contact us at info@h7biocapital.com.

AGENDA:

1:00 – 1:10 PM: Opening Remarks
Welcome and introduction to the event.

 1:10 – 1:30 PM Talk: Global Expansion & Operational Resilience: Strategic Considerations for Healthcare Startups Explore strategies for healthcare startups to navigate global expansion, and address financial challenges like tariffs and taxes.

 1:30 – 2:00 PM Panel:  Scaling Healthcare Companies and Planning for Exit Insights from investors, legal, and entrepreneurial experts on growth-stage challenges and exit planning for healthcare companies.

2:00 – 3:00 PM Medtech Startup Pitches + Q&A

  • Judges from Previous Panel

3:00 – 3:30 PM Panel:  Betting on Biotech in a Downturn: How VCs and Pharma Leaders Are Navigating Today’s Market
A discussion on the current funding climate, valuations, and how VCs and pharma BD teams are navigating uncertainty in biotech.

  • Moderator: Ella Li, PhD, Founding Partner, H7 BioCapital

  • Stefan Pflanz, PhD, Executive Director, Boehringer-Ingelheim Venture Fund

  • Jay Lin, PhD, Senior Director External Innovation DPDS, Johnson & Johnson

  • Ted Hou, PhD, Managing Partner, Berkeley Catalyst Fund

  • Additional speaker lineup to be announced soon.

 3:30 – 5:00 PM Therapeutics Startup Pitches + Q&A

  • Judges from Previous Panel

 5:00 – 5:10 PM Announcement of Competition Winners